Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical study
Osamu Yoshida(Ehime University Hospital), Yoichi Hiasa(Ehime University Hospital), Taizou Kamishita(Tokyo Ohka Kogyo (Japan)), Masataka Tsuge(Hiroshima University), Teruki Miyake(Ehime University), Sheikh Mohammad Fazle Akbar(Tokyo Shinagawa Hospital), Gerardo Guillén(Hunan City University), Takahiro Sanada(Tokyo Metropolitan Institute of Medical Science), Takashi Miyazaki, Yusuke Imai(Ehime University), Hayato Hikita(Osaka Gakuin University), Yoshio Tokumoto(Ehime University), Kyoko Tsukiyama‐Kohara(Kagoshima University), Julio Aguilar(Centro de Ingeniería Genética y Biotecnología), Masahito Shimizu(Gifu University Hospital), Mamun Al Mahtab, Michinori Kohara(Tokyo Metropolitan Institute of Medical Science)
Cited by 24
Related Papers
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
A Glycine-rich RNA-binding Protein Mediating Cold-inducible Suppression of Mammalian Cell Growth
|The Journal of Cell Biology|1997|388